Cargando…
Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors
Indications for current immune checkpoint inhibitors are expanding and now include thymic epithelial tumors (TETs). Although clinical trials on immune checkpoint inhibitors for TETs are ongoing, a rationale has not yet been established for immunotherapy for TETs. Therefore, we herein performed pheno...
Autores principales: | Yamamoto, Yoko, Iwahori, Kota, Funaki, Soichiro, Matsumoto, Mitsunobu, Hirata, Michinari, Yoshida, Tetsuya, Kanzaki, Ryu, Kanou, Takashi, Ose, Naoko, Minami, Masato, Sato, Eiichi, Kumanogoh, Atsushi, Shintani, Yasushi, Okumura, Meinoshin, Wada, Hisashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055333/ https://www.ncbi.nlm.nih.gov/pubmed/32132638 http://dx.doi.org/10.1038/s41598-020-61053-8 |
Ejemplares similares
-
The prognostic impact of programmed cell death 1 and its ligand and the correlation with epithelial‐mesenchymal transition in thymic carcinoma
por: Funaki, Soichiro, et al.
Publicado: (2019) -
Surgical treatment strategies for invasive thymoma
por: Funaki, Soichiro, et al.
Publicado: (2020) -
Preoperative evaluation and indications for pulmonary metastasectomy
por: Kanzaki, Ryu, et al.
Publicado: (2021) -
Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment
por: Iwahori, Kota, et al.
Publicado: (2019) -
Total thymectomy for thymic lymphoepithelioma-like carcinoma—report of two cases
por: Kawagishi, Sachi, et al.
Publicado: (2019)